Transition Period Comparative Data [Text Block] |
15. | TRANSITION PERIOD COMPARATIVE DATA | | | Three months ended | | | | March 31, 2015 (Unaudited) | | | | | $ | | Operating Data: | | | | | Expenses | | | | | Research and development | | | 435,671 | | Professional and consulting fees | | | 261,350 | | General and administrative | | | 167,747 | | Depreciation | | | 10,412 | | Share-based compensation expense | | | 371,637 | | | | | 1,246,817 | | Other expenses (income) | | | | | Interest expense | | | 179 | | Other income | | | (323) | | Change in fair value of warrant derivative liability | | | 6,387,473 | | Total other expense (income) | | | 6,387,329 | | | | | | | Net loss for the period | | | (7,634,146) | | Foreign exchange translation adjustment for the period | | | 24,799 | | Net loss and comprehensive loss for the period | | | (7,609,347) | | Loss per share - basic and diluted | | | (0.14) | | Weighted average number of shares outstanding basic and diluted | | | 52,726,746 | | | | | | | Cash flow Data: | | | | | Net cash used in operating activities | | | (825,483) | | Net cash used in investing activities | | | (38,820) | | Net cash provided by financing activities | | | 6,788,988 | | Effects of foreign currency exchange rate changes | | | (9,510) | | Net increase in cash and cash equivalents for the period | | | 5,915,175 | |
|